Zurich Cantonal Bank’s Crinetics Pharmaceuticals CRNX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$960K	Buy	+26,439	New	+$1.18M	﹤0.01%	1460
2025 Q4	–	Sell	-18,639	Closed	-$830K	–	2802
2025 Q3	$776K	Buy	18,639 +2,558	+16%	+$81.8K	﹤0.01%	1457
2025 Q2	$462K	Buy	16,081 +1,389	+9%	+$42.9K	﹤0.01%	1713
2025 Q1	$493K	Sell	14,692 -403	-3%	-$15.1K	﹤0.01%	1607
2024 Q4	$772K	Buy	15,095 +2,970	+24%	+$166K	﹤0.01%	1354
2024 Q3	$620K	Sell	12,125 -10	-0.1%	-$516	﹤0.01%	1425
2024 Q2	$544K	Buy	12,135 +2,952	+32%	+$136K	﹤0.01%	1433
2024 Q1	$430K	Buy	9,183 +509	+6%	+$19.9K	﹤0.01%	1570
2023 Q4	$309K	Sell	8,674 -1,515	-15%	-$46.5K	﹤0.01%	1826
2023 Q3	$303K	Hold	10,189	–	–	﹤0.01%	1694
2023 Q2	$184K	Buy	10,189 +2,321	+29%	+$46.3K	﹤0.01%	1986
2023 Q1	$126K	Buy	7,868 +627	+9%	+$11.6K	﹤0.01%	2158
2022 Q4	$133K	Sell	7,241 -164	-2%	-$2.89K	﹤0.01%	2088
2022 Q3	$145K	Hold	7,405	–	–	﹤0.01%	1955
2022 Q2	$138K	Sell	7,405 -88	-1%	-$1.76K	﹤0.01%	2021
2022 Q1	$164K	Buy	7,493 +1,110	+17%	+$22.5K	﹤0.01%	2015
2021 Q4	$181K	Buy	+6,383	New	+$157K	﹤0.01%	2128